Discover the potential benefits of outsourcing in-house dialysis services for U.S. hospitals facing rising patient volumes and operational challenges.

Intensive blood pressure control in hypertensive chronic kidney disease (CKD) provides a survival advantage and other benefits.

New research connects mild acute kidney injury (AKI) with increased risks of dementia and cognitive impairment in older ...

No previous study has investigated whether glucarpidase improves important clinical outcomes in patients with methotrexate-associated acute kidney injury (AKI).

KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

Ozempic becomes the first GLP-1 treatment option for people with type 2 diabetes and chronic kidney disease Mario Tama/Getty The Food and Drug Administration has approved Ozempic to reduce the ...

Approval was based on results from the Phase IIIb FLOW trial, which demonstrated a 24% relative risk reduction in kidney ...

Request To Download Free Sample of This Strategic Report @ The Vietnam Acute Kidney Injury (AKI) Treatment Market report provides a comprehensive analysis of the current landscape and future trends ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...